Novavax, Inc. (NVAX): Earnings News

NVAX – Reports EPS loss in-line with estimates. Slightly beats on revenues.


Key Facts Surrounding This News Item


  • NVAX had a POWR Rating of F (Strong Sell) coming into today.
  • NVAX was -0.66% below its 10-Day Moving Average coming into today.
  • NVAX was -7.59% below its 20-Day Moving Average coming into today.
  • NVAX was -16.46% below its 50-Day Moving Average coming into today.
  • NVAX was -26.45% below its 100-Day Moving Average coming into today.
  • NVAX was -26.35% below its 200-Day Moving Average coming into today.
  • NVAX had returned -3.23% year-to-date leading up to today’s news, versus a +7.93% return from the benchmark S&P 500 during the same period.

More Info About Novavax, Inc. (NVAX)


Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland. View our full NVAX ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

NVAX at a Glance

NVAX Current POWR Rating™
Overall POWR Rating™
NVAX Current Price $1.23 1.60%
More NVAX Ratings, Data, and News

NVAX Price Reaction

The day of this event (Aug. 8, 2018)
NVAX Closing Price$1.21 0.83%
NVAX Volume2,193,000
66.65% from avg
Leading up to this event
NVAX 1-mo returnN/A%
After this event
NVAX 1-day return18.37%
NVAX 3-day return11.76%
NVAX 5-day return5.51%

NVAX Price Chart



More Novavax, Inc. (NVAX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All NVAX News
Page generated in 0.9329 seconds.